Sponsor:
Tango Therapeutics, Inc.
Code:
NCT05887492
Conditions
Non Small Cell Lung Cancer
Solid Tumors, Adult
Endometrial Cancer
Pancreatic Cancer
Cervical Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TNG260
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations